Iridex Stock Price To Sales

IRIX Stock

USD 1.77 0.12 6.35%

IRIDEX fundamentals help investors to digest information that contributes to IRIDEX's financial success or failures. It also enables traders to predict the movement of IRIDEX Stock. The fundamental analysis module provides a way to measure IRIDEX's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IRIDEX stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	0.65	0.61

Price To Sales Ratio is likely to drop to 0.61 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

IRIDEX Company Price To Sales Analysis

IRIDEX's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current IRIDEX Price To Sales

0.61 X

Most of IRIDEX's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IRIDEX is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

IRIDEX Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for IRIDEX is extremely important. It helps to project a fair market value of IRIDEX Stock properly, considering its historical fundamentals such as Price To Sales. Since IRIDEX's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IRIDEX's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IRIDEX's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Short Term Debt	Net Tangible Assets	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total	Short Long Term Debt
Total Assets		0.66	-0.72	-0.26	0.5	0.88	0.47	0.96	0.31	0.55	0.09	0.63	-0.72	-0.91	0.39	0.27	-0.07	0.11	0.25	-0.03	-0.03
Total Stockholder Equity	0.66		-0.79	0.48	-0.25	0.43	-0.35	0.67	-0.35	-0.01	-0.39	0.03	-0.59	-0.59	0.84	-0.28	0.61	0.58	-0.55	0.52	0.52
Net Debt	-0.72	-0.79		-0.14	0.06	-0.46	0.02	-0.83	0.01	-0.25	0.0	-0.4	0.45	0.62	-0.59	-0.07	-0.43	-0.56	0.24	-0.44	-0.44
Retained Earnings	-0.26	0.48	-0.14		-0.78	-0.51	-0.9	-0.25	-0.63	-0.81	-0.56	-0.67	0.19	0.38	0.67	-0.88	0.9	0.77	-0.84	0.56	0.56
Accounts Payable	0.5	-0.25	0.06	-0.78		0.65	0.91	0.42	0.69	0.62	0.31	0.7	-0.33	-0.51	-0.39	0.54	-0.74	-0.51	0.87	-0.69	-0.69
Net Receivables	0.88	0.43	-0.46	-0.51	0.65		0.6	0.79	0.35	0.78	0.22	0.67	-0.62	-0.87	0.17	0.56	-0.4	-0.26	0.41	-0.15	-0.15
Total Liab	0.47	-0.35	0.02	-0.9	0.91	0.6		0.4	0.83	0.74	0.6	0.77	-0.2	-0.44	-0.53	0.7	-0.81	-0.54	0.95	-0.6	-0.6
Total Current Assets	0.96	0.67	-0.83	-0.25	0.42	0.79	0.4		0.22	0.5	0.05	0.61	-0.72	-0.88	0.42	0.28	0.02	0.17	0.16	0.01	0.01
Intangible Assets	0.31	-0.35	0.01	-0.63	0.69	0.35	0.83	0.22		0.57	0.68	0.59	0.03	-0.19	-0.59	0.46	-0.61	-0.22	0.83	-0.25	-0.25
Common Stock	0.55	-0.01	-0.25	-0.81	0.62	0.78	0.74	0.5	0.57		0.59	0.75	-0.34	-0.63	-0.35	0.91	-0.7	-0.52	0.59	-0.09	-0.09
Property Plant Equipment	0.09	-0.39	0.0	-0.56	0.31	0.22	0.6	0.05	0.68	0.59		0.49	0.36	0.01	-0.44	0.64	-0.56	-0.29	0.64	-0.13	-0.13
Current Deferred Revenue	0.63	0.03	-0.4	-0.67	0.7	0.67	0.77	0.61	0.59	0.75	0.49		-0.28	-0.64	-0.16	0.68	-0.48	-0.21	0.62	-0.28	-0.28
Good Will	-0.72	-0.59	0.45	0.19	-0.33	-0.62	-0.2	-0.72	0.03	-0.34	0.36	-0.28		0.84	-0.24	-0.12	0.04	0.11	0.03	0.05	0.05
Short Term Debt	-0.91	-0.59	0.62	0.38	-0.51	-0.87	-0.44	-0.88	-0.19	-0.63	0.01	-0.64	0.84		-0.26	-0.4	0.16	0.08	-0.19	0.03	0.03
Net Tangible Assets	0.39	0.84	-0.59	0.67	-0.39	0.17	-0.53	0.42	-0.59	-0.35	-0.44	-0.16	-0.24	-0.26		-0.49	0.74	0.63	-0.62	0.31	0.31
Capital Surpluse	0.27	-0.28	-0.07	-0.88	0.54	0.56	0.7	0.28	0.46	0.91	0.64	0.68	-0.12	-0.4	-0.49		-0.77	-0.67	0.59	-0.22	-0.22
Net Invested Capital	-0.07	0.61	-0.43	0.9	-0.74	-0.4	-0.81	0.02	-0.61	-0.7	-0.56	-0.48	0.04	0.16	0.74	-0.77		0.9	-0.85	0.6	0.6
Net Working Capital	0.11	0.58	-0.56	0.77	-0.51	-0.26	-0.54	0.17	-0.22	-0.52	-0.29	-0.21	0.11	0.08	0.63	-0.67	0.9		-0.58	0.6	0.6
Capital Stock	0.25	-0.55	0.24	-0.84	0.87	0.41	0.95	0.16	0.83	0.59	0.64	0.62	0.03	-0.19	-0.62	0.59	-0.85	-0.58		-0.69	-0.69
Long Term Debt Total	-0.03	0.52	-0.44	0.56	-0.69	-0.15	-0.6	0.01	-0.25	-0.09	-0.13	-0.28	0.05	0.03	0.31	-0.22	0.6	0.6	-0.69		1.0
Short Long Term Debt	-0.03	0.52	-0.44	0.56	-0.69	-0.15	-0.6	0.01	-0.25	-0.09	-0.13	-0.28	0.05	0.03	0.31	-0.22	0.6	0.6	-0.69	1.0

Click cells to compare fundamentals

IRIDEX Price To Sales Historical Pattern

Today, most investors in IRIDEX Stock are looking for potential investment opportunities by analyzing not only static indicators but also various IRIDEX's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of IRIDEX price to sales as a starting point in their analysis.

IRIDEX Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict IRIDEX

Price To Sales Ratio Over Time

IRIDEX Price To Sales Ratio

Price To Sales Ratio

0.61

At this time, IRIDEX's Price To Sales Ratio is fairly stable compared to the past year.

Based on the latest financial disclosure, IRIDEX has a Price To Sales of 0.608 times. This is 97.16% lower than that of the Health Care Equipment & Supplies sector and 87.28% lower than that of the Health Care industry. The price to sales for all United States stocks is 94.68% higher than that of the company.

IRIDEX Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IRIDEX's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IRIDEX could also be used in its relative valuation, which is a method of valuing IRIDEX by comparing valuation metrics of similar companies.

IRIDEX is currently under evaluation in price to sales category among its peers.

IRIDEX Fundamentals

	Return On Equity	-1.5
	Return On Asset	-0.21
	Profit Margin	(0.23) %
	Operating Margin	(0.16) %
	Current Valuation	29.62 M
	Shares Outstanding	16.64 M
	Shares Owned By Insiders	20.67 %
	Shares Owned By Institutions	19.97 %
	Number Of Shares Shorted	309.83 K
	Price To Earning	(6.30) X
	Price To Book	7.41 X
	Price To Sales	0.61 X
	Revenue	51.87 M
	Gross Profit	25.37 M
	EBITDA	(7.45 M)
	Net Income	(9.57 M)
	Cash And Equivalents	17.97 M
	Cash Per Share	1.12 X
	Total Debt	2.75 M
	Debt To Equity	0.11 %
	Current Ratio	3.19 X
	Book Value Per Share	0.16 X
	Cash Flow From Operations	(6.75 M)
	Short Ratio	9.64 X
	Earnings Per Share	(0.67) X
	Price To Earnings To Growth	(0.44) X
	Target Price	2.0
	Number Of Employees	111
	Beta	0.81
	Market Capitalization	29.45 M
	Total Asset	34.44 M
	Retained Earnings	(79.04 M)
	Working Capital	14.48 M
	Current Asset	30.77 M
	Current Liabilities	7.43 M
	Net Asset	34.44 M

About IRIDEX Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IRIDEX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IRIDEX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IRIDEX based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
MSFT	Microsoft

Additional Tools for IRIDEX Stock Analysis

When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC